Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

PAIN MEDICINE & REHABILITATION GROUP PC

NPI: 1770516080 · BRENTWOOD, TN 37027 · Pain Medicine (Physical Medicine & Rehabilitation) Physician · NPI assigned 07/09/2006

$4.17M
Total Medicaid Paid
163,318
Total Claims
138,140
Beneficiaries
45
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialNWOFIA, JOHN (MEDICAL DIRECTOR)
NPI Enumeration Date07/09/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 28,143 $1.05M
2019 29,347 $696K
2020 23,840 $534K
2021 22,168 $505K
2022 23,900 $576K
2023 20,014 $472K
2024 15,906 $339K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 67,457 58,074 $1.97M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 41,460 36,548 $781K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 14,113 11,966 $608K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 20,408 17,241 $264K
64635 1,094 598 $81K
27096 983 849 $79K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 1,248 1,092 $78K
64636 1,125 592 $52K
64493 1,189 598 $44K
64483 775 572 $40K
62323 357 266 $35K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 1,841 1,642 $35K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,676 1,534 $27K
64494 1,111 544 $19K
64495 675 319 $14K
95886 180 155 $11K
62321 86 65 $6K
95909 81 66 $4K
J1030 Injection, methylprednisolone acetate, 40 mg 1,063 791 $4K
99441 584 465 $3K
20610 155 103 $3K
99215 Prolong outpt/office vis 64 52 $3K
62370 136 100 $3K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 48 43 $2K
99205 Prolong outpt/office vis 28 25 $2K
20552 81 58 $2K
L0642 Lumbar orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf 41 26 $2K
81025 375 317 $1K
99406 194 151 $813.97
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 1,200 848 $784.54
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 63 61 $583.98
20611 21 13 $520.83
J1100 Injection, dexamethasone sodium phosphate, 1 mg 895 688 $512.44
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 120 84 $421.02
20553 15 12 $402.39
J1010 Injection, methylprednisolone acetate, 1 mg 54 46 $233.05
J2704 Injection, propofol, 10 mg 721 432 $207.25
80305 67 41 $202.50
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 30 28 $76.00
J1885 Injection, ketorolac tromethamine, per 15 mg 41 28 $39.58
J2250 Injection, midazolam hydrochloride, per 1 mg 27 17 $4.85
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 169 110 $4.81
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 125 80 $0.10
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 1,076 768 $0.00
77003 66 32 $0.00